Focus: AstraZeneca: Rare Diseases, Cardiovascular & Metabolics, Oncology, Respiratory & Autoimmunity. Alexion: Rare Diseases-Neurology, Hematology, Nephrology, Metabolics & Bone Metabolism.
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines in Oncology, and Biopharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
At Alexion, our mission is to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, as well as supportive technologies and healthcare services.